Madrigal Pharmaceuticals, Inc. (MDGL)

435.01 -1.86 (-0.43%) USD  |  NASDAQ  |  Feb 20, 16:00
428.00 -7.01 (-1.61%) After-Hours: 07:30
More

Madrigal Pharmaceuticals Sell Recommendations

Sell Recommendations Chart

View Sell Recommendations for MDGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Sell Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Sell Recommendations Range, Past 5 Years

View Sell Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Sell Recommendations Benchmarks

View Sell Recommendations Benchmarks
Start Trial
Pfizer Inc. Upgrade
Eli Lilly & Co. Upgrade
Insmed, Inc. Upgrade
Johnson & Johnson Upgrade
Crinetics Pharmaceuticals, Inc. Upgrade